CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
IRL757drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06699628
NCT06699628Phase 1Completed
CompareCT.gov

A Single-centre, Open-label, Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers

Integrative Research Laboratories AB·interventional·Posted Nov 21, 2024·Updated Feb 5, 2026

In Brief

A Phase 1 clinical trial evaluating IRL757 for Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects and Apathy. Completed, enrolled 12 participants across 1 site.

Detailed Summary

This is a phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNot Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects, Apathy
CountriesSweden
Collaborators--

Timeline

Phase 1CompletedFinished
20252026
First PostedNov 21, 2024
Enrollment StartSep 23, 2024
Primary CompletionNov 11, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.6 years ago

Interventions

IRL757drug

IRL757 capsules